fluconazole has been researched along with bradykinin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Staercke, C; Hayek, S; Hooper, WC; Kavtaradze, N; Lin, J; Manatunga, A; Murrow, JR; Ozkor, MA; Quyyumi, AA; Rahman, AM | 1 |
Ament, Z; Cheriyan, J; Griffin, JL; Gutterman, DD; Lazaar, AL; Mayer, RJ; Newby, DE; Tal-Singer, R; Wilkinson, IB; Yang, L | 1 |
2 trial(s) available for fluconazole and bradykinin
Article | Year |
---|---|
Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.
Topics: Adult; Biological Factors; Bradykinin; Cytochrome P-450 Enzyme System; Female; Fluconazole; Forearm; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Potassium Channels, Calcium-Activated; Regional Blood Flow; Tetraethylammonium; Tissue Plasminogen Activator; Vasodilation | 2014 |
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.
Topics: 8,11,14-Eicosatrienoic Acid; Adult; Aged; Blood Vessels; Bradykinin; Case-Control Studies; Cyclohexylamines; Endothelium, Vascular; Epoxide Hydrolases; Fluconazole; Forearm; Humans; In Vitro Techniques; Male; Middle Aged; Overweight; Plethysmography; Pulmonary Disease, Chronic Obstructive; Smoking; Triazines; Vasodilation; Vasodilator Agents | 2017 |